WO2008125592A1 - Improved process for preparing o-chloromethylphenylglyoxylic esters, improved process for preparing (e)-2-(2-chloromethylphenyl)-2-alkoximinoacetic esters, and novel intermediates for their preparation - Google Patents

Improved process for preparing o-chloromethylphenylglyoxylic esters, improved process for preparing (e)-2-(2-chloromethylphenyl)-2-alkoximinoacetic esters, and novel intermediates for their preparation Download PDF

Info

Publication number
WO2008125592A1
WO2008125592A1 PCT/EP2008/054354 EP2008054354W WO2008125592A1 WO 2008125592 A1 WO2008125592 A1 WO 2008125592A1 EP 2008054354 W EP2008054354 W EP 2008054354W WO 2008125592 A1 WO2008125592 A1 WO 2008125592A1
Authority
WO
Grant status
Application
Patent type
Prior art keywords
formula
compound
reaction
preparing
esters
Prior art date
Application number
PCT/EP2008/054354
Other languages
French (fr)
Other versions
WO2008125592B1 (en )
Inventor
John-Matthias Wiegand
Karsten Luettgen
Wolfgang Skranc
Original Assignee
Dsm Fine Chemicals Austria Nfg Gmbh & Co Kg
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F3/00Compounds containing elements of Groups 2 or 12 of the Periodic System
    • C07F3/003Compounds containing elements of Groups 2 or 12 of the Periodic System without C-Metal linkages
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07BGENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B49/00Grignard reactions
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C249/00Preparation of compounds containing nitrogen atoms doubly-bound to a carbon skeleton
    • C07C249/04Preparation of compounds containing nitrogen atoms doubly-bound to a carbon skeleton of oximes
    • C07C249/12Preparation of compounds containing nitrogen atoms doubly-bound to a carbon skeleton of oximes by reactions not involving the formation of oxyimino groups
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C67/00Preparation of carboxylic acid esters
    • C07C67/30Preparation of carboxylic acid esters by modifying the acid moiety of the ester, such modification not being an introduction of an ester group
    • C07C67/307Preparation of carboxylic acid esters by modifying the acid moiety of the ester, such modification not being an introduction of an ester group by introduction of halogen; by substitution of halogen atoms by other halogen atoms

Abstract

An improved process for preparing o-chloromethylphenylglyoxylic esters of the formula (I) which comprises converting a compound of the formula (II) by reaction with magnesium into the corresponding Grignard reagent which is then reacted with a compound of the formula (III) to give the compound of the formula (IV) which is then cleaved by reaction with a chloroformic ester of the formula ClCOOR4 or by reaction with phosgene to give the compound of the formula (I), followed by the isolation of the compound of the formula (I), and also an improved process for preparing (E)-2-(2-chloromethylphenyl)- 2-alkoximinoacetic esters of the formula (VII) and intermediates for their preparation.

Description

IMPROVED PROCESS FOR PREPARING O-CHLOROMETHYLPHENYLGLYOXYLIC

ESTERS. IMPROVED PROCESS FOR PREPARING (EV2-(2- CHLOROMETHYLPHENYLV2-ALKOXIMINOACETIC ESTERS. AND NOVEL

INTERMEDIATES FOR THEIR PREPARATION

The present invention relates to an improved process for preparing o-chloromethylphenylglyoxylic esters, an improved process for preparing (E)-2-(2-chloromethylphenyl)-2-alkoximinoacetic esters and novel intermediates for preparing these esters. o-Chloromethylphenylglyoxylic esters are important intermediates for preparing agrochemically active compounds or microbicides of the methoximinophenylglyoxylic ester series, as described, for example, in EP 0 254 426, EP 0 782 982, WO 95/18789 and WO 95/21 153.

According to EP O 782 982, for example, methyl o-(N,N- dimethylaminomethyl)phenylglyoxylate or methyl o-piperidinomethylphenylglyoxylate are obtained by reacting N-benzyldimethylamine and N-benzylpiperidine, respectively, with an organolithium compound, followed by reaction with a dialkyl oxalate compound, with a chloroformic ester to give the corresponding o-chloromethylphenylglyoxylic esters. Disadvantages of this reaction sequence are the use of expensive organolithium compounds and low temperatures of up to -500C required for this reaction, which make an industrial application difficult.

JP 2003-026640 discloses that 2-(morpholinomethyl)chlorobenzene, obtained by reaction of 2-chlorobenzyl chloride with morpholine, can be converted via a Grignard reaction and reaction with a dialkyl oxalate and to the corresponding o-(morpholinomethyl)phenylglyoxylic ester, which is then isolated from the reaction mixture by aqueous acidic work-up. This reaction sequence has the disadvantage of the aqueous acidic work-up of the basic amine product, which results in high product losses and/or large volumes to recover the product. (E)-2-(2-Chloromethylphenyl)-2- alkoximinoacetic esters are likewise important intermediates for preparing agrochemically active compounds or microbicides of the methoximinophenylglyoxylic ester series, as described, for example, in EP 0 254 426, EP 0 782 982, WO 95/18789 and WO 95/21 153.

According to EP 0 782 982, for example, methyl (E)-2-(2- chloromethylphenyl)-2-methoximinoacetate is prepared by treating a solution of the (E/Z) isomer mixture of methyl 2-(2-chloromethylphenyl)-2-methoximinoacetate in methylcyclohexane with hydrogen chloride gas. This process has the disadvantage that a corrosive gaseous substance is used, which requires increased expense for apparatus.

It was an object of the present invention to provide an improved process for preparing o-chloromethylphenylglyoxylic esters which does not require low- temperature reaction conditions, does not require complicated and/or yield-reducing work-up steps and which affords the desired end products in high yield. It was another object of the present invention to provide an improved process for preparing (E)-2-(2- chloromethylphenyl)-2-alkoximinoacetic esters which does not require any corrosive gaseous substance.

Accordingly, the present invention provides an improved process for preparing o-chloromethylphenylglyoxylic esters of the formula

Figure imgf000004_0001
in which

R is a reaction-inert radical, n is from 0 to 4 and

R1 may be a Ci-C8-alkyl radical, which comprises converting a compound of the formula

Figure imgf000004_0002
in which n and R are as defined above, R2 and R3 independently of one another may be Ci-Ci2-alkyl, Ci-Ci2-alkenyl,
Figure imgf000004_0003
or C3-C6-cycloalkyl or R2 and R3 together with the nitrogen atom may be a 6- or 7-membered ring which, in addition to the nitrogen atom, may contain a further nitrogen atom or oxygen atom, by reaction with magnesium into the corresponding Grignard reagent which is then reacted with a compound of the formula

Figure imgf000005_0001
in which R1 is as defined above to give the compound of the formula

Figure imgf000005_0002
in which n, R, R1 , R2 and R3 are as defined above, which is then cleaved by reaction with a chloroformic ester of the formula CIC00R4 in which R4 may be a C-i.Cβ-alkyl radical or by reaction with phosgene to give the compound of the formula (I), followed by the isolation of the compound of the formula (I). The process according to the invention is suitable for preparing o-chloromethylphenylglyoxylic esters of the formula (I).

In formula (I), R is a reaction-inert radical, i.e. the radical R can be chosen as desired, provided it is inert to the reaction conditions. Examples of such radicals are

Figure imgf000005_0003
radicals, preferably Ci-C6-alkyl radicals, Ci-Ci2-alkenyl radicals, preferably Ci-C6-alkenyl radicals, Ci-Ci2-alkoxy radicals, preferably CrC6- alkoxy radicals, phenyl, benzyl, nitro, etc. n may be O, 1 , 2, 3 or 4; preferably, n = O.

R1 is a d-Cβ-alkyl radical, such as, for example, methyl, ethyl, n- propyl, isopropyl, n-butyl, sec-butyl, tert-butyl, etc. Preferably, R1 is a Ci-C2-alkyl radical, particularly preferably methyl.

The starting material used for the process according to the invention is a compound of the formula (II).

In formula (II), R and n are as defined above.

R2 and R3 independently of one another are Ci-Ci2-alkyl, CrCi2- alkenyl, Ci-Ci2-alkoxyalkyl or C3-C6-cycloalkyl. - A-

Furthermore, R2 and R3 together with the nitrogen atom may be a 6- or 7-membered ring which, in addition to the nitrogen atom, may contain a further nitrogen atom or oxygen atom, preferably a 6-membered ring, particularly preferably morpholine. Optionally substituted 2-(morpholinomethyl)chlorobenzenes of the formula (II) are known, for example, from JP 2003-026640 and can be prepared analogously to the process described in this publication from 2-chlorobenzyl chloride and morpholine.

In the first step of the process according to the invention, the compound of the formula (II) is reacted with magnesium to give the corresponding Grignard reagent.

To this end, 1 to 3 equivalents, preferably 1 to 1.5 equivalents, based on the compound of the formula (II), of magnesium are heated in a suitable solvent at a temperature of from 300C to 700C, preferably from 40°C to 600C, and a catalytic amount of dibromoethane or iodine, about 0.01 to 0.5 equivalents, preferably 0.03 to 0.12 equivalents, is added.

Suitable solvents are, for example, ethers, such as, for example, diethyl ether, dibutyl ether, tert-butyl methyl ether, tetrahydrofuran, 1 ,4-dioxane, diethylene glycol dimethyl ether, etc., aromatic hydrocarbons, such as, for example, toluene, benzene, ethylbenzene, xylenes, etc., amines, such as, for example, triethylamine, pyridine, piperidine, etc., and mixtures of these. Particularly suitable is a mixture of THF and toluene.

The compound of the formula (II) is then added to the mixture obtained in this manner, and stirring is continued at from 60°C to 130°C, preferably from 700C to 100°C, for a further 1 to 24 hours.

Magnesium which has not been consumed is then filtered off, and - if a solvent mixture has been used which, as polar component, contains an ether, such as, for example, THF, diethyl ether, 1 ,4-dioxane, etc., which gives unwanted byproducts in the subsequent reaction with the compound of the formula (III) - a solvent exchange for an unpolar solvent, such as, for example, dibutyl ether, tert-butyl methyl ether, diethylene glycol dimethyl ether, toluene, benzene, ethylbenzene, xylenes, etc., is carried out.

The solution of the Grignard reagent obtained in this manner is, in the second step of the process according to the invention, at a reaction temperature of from -20°C to +200C, preferably from -100C to +10°C, added to a solution, cooled to from -200C to +100C, preferably to from -10°C to +5°C, of the compound of the formula (III).

Here, the compound of the formula (III) is employed in an amount of from 1 to 3 equivalents, preferably from 1.1 to 2 equivalents and particularly preferably from 1.3 to 1.7 equivalents, based on the compound of the formula (II).

Suitable solvents are, for example, dibutyl ether, tert-butyl methyl ether, diethylene glycol dimethyl ether, toluene, benzene, ethylbenzene, xylenes, etc., and also mixtures of these; toluene is particularly suitable.

After the addition has ended, the reaction temperature is kept at this temperature for some time (from 10 minutes to 10 hours, preferably from 30 minutes to 5 hours, particularly preferably from 1 to 2 hours) and then slowly (over a period of several hours) brought to room temperature.

The suspension obtained in this manner, which comprises the compound of the formula (IV), is then used directly and without further work-up for the next step.

Aminoketo ester Mg acetals of the formula (IV) and their use for preparing agrochemically active compounds are novel, and thus also part of the subject matter of the present invention.

By aqueous work-up of the resulting suspension, which comprises the compound of the formula (IV), it is possible to isolate the corresponding o- aminomethylphenylglyoxylic esters. In particular, methyl o- morpholinemethylphenylglyoxylate of the formula

Figure imgf000007_0001
and its use for preparing agrochemically active compounds are novel, and thus also form part of the subject matter of the present invention.

The compound of the formula (V) can be converted by oximation, as described, for example, in EP 0 254 426 and EP 0 782 982, into the corresponding methyl 2-(2-morpholinomethylphenyl)-2-methoximinoacetate of the formula

Figure imgf000008_0001

The compound of the formula (Vl) and its use for preparing agrochemically active compounds are novel, and thus also part of the subject matter of the present invention. In the third step of the process according to the invention, a chloroformic ester of the formula CICOOR4 or phosgene is added to the suspension which comprises the compound of the formula (IV). Here, R4 is a Ci-C8-alkyl radical. Preferably, R4 is methyl or ethyl, particularly preferably methyl.

The chloroformic ester of phosgene is employed in an amount of from 1 to 5 equivalents, preferably from 1.5 to 3 equivalents, based on (II).

The reaction mixture is then heated at 500C to 1200C, preferably from 700C to 1100C, for a period of from 30 minutes to 6 hours, preferably from 1 to 3 hours. After cooling of the reaction mixture to room temperature, an aqueous acidic work-up is carried out for removing the cleavage product from the desired compound of the formula (I).

Using the process according to the invention, the desired o-chloromethylphenylglyoxylic esters of the formula (I) are obtained in a simple manner in high yields and purities.

The o-chloromethylphenylglyoxylic esters of the formula (I) prepared according to the invention are highly suitable for preparing the corresponding

2-(2-chloromethylphenyl)2-alkoximinoacetic esters by oximation, as described, for example, in EP 0 254 426 and EP 0 782 982. These compounds are obtained as an E/Z mixture.

Accordingly, the present invention also provides an improved process for preparing (E)-2-(2-chloromethylphenyl)-2-alkoximinoacetic esters of the formula

Figure imgf000009_0001
in which

R is a reaction-inert radical, n is from 0 to 4 and

R1 and R5 independently of one another may be Ci-C8-alkyl radicals, which comprises treating a compound of the formula

Figure imgf000009_0002
in which n, R, R1 and R5 are as defined above with an aqueous mineral acid.

The process according to the invention is suitable for preparing (E)-2-(2-chloromethylphenyl)-2-alkoximinoacetic esters of the formula (VII).

In formula (VII), R is a reaction-inert radical, i.e. the radical R can be chosen as desired, provided it is inert to the reaction conditions. Examples of such radicals are Ci-Ci2-alkyl radicals, preferably Ci-C6-alkyl radicals, Ci-Ci2-alkenyl radicals, preferably Ci-C6-alkenyl radicals, Ci-Ci2-alkoxy radicals, preferably Ci-C6-alkoxy radicals, phenyl, benzyl, nitro, etc. n may be 0, 1 , 2, 3 or 4; preferably, n = 0.

R1 and R5 independently of one another are Ci-C8-alkyl radicals, such as, for example, methyl, ethyl, n-propyl, isopropyl, n-butyl, sec-butyl, tert-butyl, etc. Preferably, R1 and R5 independently of one another are Ci-C2-alkyl radicals, particularly preferably methyl.

The starting material used for the process according to the invention is a compound of the formula (VIII) in which n, R, R1 and R5 are as defined above. Compounds of the formula (VIII) are known and can be prepared by oximation of o-chloromethylphenylglyoxylic esters of the formula (I), as described, for example, in EP 0 254 426 and EP 0 782 982.

In the process according to the invention, the compound of the formula (VIII) is reacted with an aqueous mineral acid to give the compound of the formula (VII).

To this end, from 0.5 to 20 equivalents, preferably from 1 to 10 equivalents, based on the compound of the formula (VIII), of mineral acid are heated in the presence of a suitable solvent at a temperature of from 200C to 1000C, preferably from 60°C to 900C.

Suitable mineral acids are, for example, hydrochloric acid, sulfuric acid, phosphoric acid, nitric acid, etc. Hydrochloric acid is particularly suitable. Suitable solvents are, for example, hydrocarbons, such as, for example, pentane, hexane, heptane, etc., and also aromatic hydrocarbons, such as, for example, toluene, benzene, ethylbenzene, xylenes, etc., and also mixtures of these. Toluene is particularly suitable.

The organic phase is then separated off, the solvent is removed and the residue, which contains the compound of the formula (VII), is crystallized from a suitable solvent. Suitable solvents are, for example, alcohols, such as methanol, ethanol, propanol, isopropanol, etc., hydrocarbons, such as, for example, pentane, hexane, heptane, etc., and also aromatic hydrocarbons, such as, for example, toluene, benzene, ethylbenzene, xylenes, etc., and also mixtures of these. Methanol is particularly suitable. A particularly useful compound of Formula VII is CLMO, wherein n =

0 and wherein R1 and R5 are methyl.

Strobilurines are a type of fungicides that inhibit the respiratory sytem of the fungi. Strobilurines may be synthesized starting from compounds according to Formula VII. The known strobilurines Kresoxim-methyl and Dimoxystrobin, respectively may be synthesized from CLMO by substitution reaction with the respective phenol as shown in examples 7 and 8. Variations on this synthesis may easily be employed by the skilled person using the disclosure of the present invention. Example 1 : Synthesis of 2-chlorobenzylmorpholine (Na) (not subject matter of the invention)

Figure imgf000011_0001

2-Chlorobenzyl chloride (1 eq., 200 g) was dissolved in toluene (400 ml), 15% strength NaOH (1.3 eq., 430 g) and morpholine (1.2 eq., 130 g) were added and the mixture was heated at the boil for 16 hours. After cooling to room temperature, the phases were separated, the organic phase was washed with 200 ml of water and the phases were again separated. Subsequently, the organic phase was dried by azeotropic distillation and the solvent was removed completely under reduced pressure. This gave 2-(morpholinomethyl)chlorobenzene (Na) (260 g, yield: 98.9%) in the form of a colorless oil.

Example 2: Synthesis of methyl o-morpholinomethylphenylglvoxylate methylmaqnesium chloride acetal (IVa) by Griqnard reaction of the compound of the formula (Na) and reaction with dimethyl oxalate (subject matter of the invention)

Figure imgf000011_0002

(Ha) Ia) (IVa)

Magnesium (1.1 eq., 10.56 g) was added to a mixture of toluene (130 ml) and THF (100 ml), and the mixture was heated to 500C with stirring. Dibromoethane (0.1 eq., 7.52 g) was then added slowly, and after a few minutes a strong exothermic reaction with vigorous foaming could be observed. After the exothermic reaction had subsided, the mixture was heated to the boil (about 83°C), and the temperature was maintained for 5 minutes. At the boil, 2-

(morpholinomethyl)chlorobenzene (Na) (1.0 eq., 84.56 g) was added dropwise over a period of 5 minutes, and the mixture was kept at the boil. 15 minutes after the addition of 2-(morpholinomethyl)chlorobenzene (Na) had ended (temperature of the reaction mixture about 900C), THF (30 ml) was added, and the temperature of the mixture decreased to about 86°C. One hour after the end of the addition of 2- (morpholinomethyl)chlorobenzene, THF (50 ml) was added, the temperature of the reaction vessel was adjusted to 65°C and the mixture was kept at this temperature for 12 hours. The resulting brown solution of the compound of the formula (IVa) was filtered through a G3 frit and, at 500C and under reduced pressure, concentrated to 300 ml. In the solvent exchange that followed, twice toluene (100 ml) was added and in each case the same amount of solvent mixture was distilled off at 500C under reduced pressure. This gave a brown viscous oil which was cooled to 00C and then, over a period of one hour, added dropwise to a solution, cooled to -5°C, of dimethyl oxalate (1.5 eq., 70.80 g) in toluene (375 ml). After the addition had ended, the temperature was kept at -5°C for two hours and then, over a period of 12 hours, increased to room temperature. The resulting yellowish suspension of the compound of the formula (IVa) was used without further treatment in the next step (Example 3). Characterization: IR: v = 3295, 1641 , 1321 cm"1.

Example 3: Methyl o-morpholinemethylphenylqlvoxylate (V) (subject matter of the invention)

Figure imgf000012_0001
The compound of the formula (V) can be isolated by aqueous work-up of the suspension of the compound of the formula (IVa). Characterization: 1H- NMR (300 MHz, CDCI3): δ = 2.38 (t, 4 H), 3.59 (t, 6 H), 3.88 (s, 3 H), 7.17-7.44 (m, 4 H). Example 4: Methyl 2-(2-morpholinomethylphenyl)-2-methoximinoacetate (Vl) (subject matter of the invention)

Figure imgf000013_0001

By oximation of the compound of the formula (V), for example as described in EP O 254 426 and EP O 782 982, it is possible to isolate the compound of the formula (Vl). Characterization: 1H-NMR (400 MHz, CDCI3): δ = 2.32-2.34 (d, 4 H), 3.56-3.59 (m, 4 H), 3.88 (s, 2 H), 3.90 (s, 3 H), 3.99 (s, 3 H), 7.12-7.33 (m, 4 H).

Example 5: Synthesis of methyl o-chloromethylphenylglvoxylate (Ia) by reaction of the compound of the formula (IVa) with methyl chloroformate (subject matter of the invention)

Figure imgf000013_0002

(IVa) (Ia)

Methyl chloroformate (2.0 eq., based on the compound of the formula (Na), 76.8 g) was added to the suspension, obtained in example 2, of the compound of the formula (IVa) in toluene, and the mixture was heated in a closed reaction vessel (autoclave) at 10O0C for two hours, and a pressure increase to 12 bar was observed. After the reaction mixture had cooled to room temperature, the resulting brown suspension was washed twice with in each case 10O ml of cone. HCI and once with 100 ml of water, the organic phase was dried over Na2SO4 and the solvent was removed under reduced pressure. This gives methyl o-chloromethylphenylglyoxylate (Ia) (53.7 g, content: about 48% (NMR), yield: 30.3% (starting from the compound of the formula (Na)) in the form of a brown oil.

Example 6: Synthesis of methyl (E)-2-(2-chloromethylphenyl)-2-methoximinoacetate (Vila) by reaction of the compound of the formula (Ia) with methoxyamine hydrochloride (not subject matter of the invention) and (E/Z)-isomerization with aqueous HCI (subject matter of the invention)

CHoONH9 * HCI HCI

Figure imgf000014_0001
Figure imgf000014_0002
Figure imgf000014_0003

(Ia) (Villa) (Vila)

The brown oil of the compound of the formula (Ia) obtained in example 3 was dissolved in methanol (100 ml), a 30% strength solution of methoxyamine hydrochloride in H2O (2.0 eq., based on the compound of the formula (Ia), 70.0 g), which had been adjusted to pH = 3 beforehand, was added, and the mixture was stirred at 55°C for 1.5 hours. The reaction mixture was cooled and extracted twice with toluene (100 ml). The combined organic phases, which contain the compound of the formula (Villa), were washed twice with cone, hydrochloric acid (20 ml), cone, hydrochloric acid (50 ml) was then added and the mixture was stirred at 800C for 2 hours. After the reaction mixture had cooled to room temperature, the phases were separated, the organic phase was washed once with water (50 ml), the phases were separated and the organic phase was freed from the solvent under reduced pressure. The oily residue was taken up in methanol (30 ml) and cooled at -18°C for 16 hours, and the resulting precipitated crystals of methyl 2-(2- chloromethylphenyl)-2-methoximinoacetate (Vila) were isolated (11.63 g, yield: 73%, E/Z isomer ratio: about 99:1 ). Example 7: Synthesis of Kresoxim-methyl from CLMO

Figure imgf000015_0001

CLMO Kreosim-methyl

To a mixture of o-Kresol (2.0 g, 18 mmol) and potassium carbonate (6.0 g, 43 mmol) in DMF (6 mL), a solution of CLMO in DMF (45 w/w%, 9.7 g, 18 mmol) was added at room temperature. Then the suspension was heated to 500C upon stirring for 64 hours. Water (100 mL) was subsequently added and the aqueous phase was extracted with ethyl acetate (3 x 70 mL). The combined organic phases were washed with water (1 x 100 mL), dried over sodium sulfate and then volatile compounds were evaporated in vacuo to give an orange-red oil (5.4 g, 59 area% Kresoxim-methyl according to GC). The product was purified by medium-pressure column chromatography using silica 60 and heptane/ethyl acetate (7/1 ) as eluent. Product-containing fractions were combined and dried in vacuo to give Kresoxim- methyl as a white solid (0.5 g).

GC: 99 area% Kresoxim-methyl. GC/MS (El): [M]+ found (313). 1H NMR (CDCI3) δ = 7.58 (d, 1 H, J = 7.6 Hz, Harom), 7.47-7.37 (m, 2H,

Harom), 7.21 (dd, 1 H, J1 = 7.6 Hz, J2 = 1.2 Hz, Harom), 7.12 (m, 2H, Harom), 6.85 (m, 1 H, Harom), 6.77 (d, 1 H, J = 8,4 Hz), 4.95 (s, 2H, CH2), 4.01 (s, 3H, NO-CH3), 3.82 (s, 3H, COOCH3), 2,25 (s, 3H, Ar-CH3).

13C NMR (CDCI3) δ = 163.3 (C=O), 156.6, 149.4 (C=N), 135.8, 130.8, 130.7, 129.7, 129.0, 128.6, 127.6, 127.0, 126.8, 120.7, 1 11.2 (all Carom), 68.1 (CH2), 63.9 (NOCH3), 53.0 (COOCH3), 16.31 (Ar-CH3). Example 8: Synthesis of Dimoxystrobin from CLMO

Figure imgf000016_0001

CLMO Dimoxystrobin

To a mixture of 2,5-dimethylphenol (2.0 g, 16 mmol) and potassium carbonate (5.3 g, 38 mmol) in DMF (6 mL), a solution of CLMO in DMF (45 w/w%, 9.7 g, 18 mmol) was added at room temperature. Then the suspension was heated to 500C upon stirring for 64 hours. Water (100 mL) was subsequently added and the aqueous phase was extracted with ethyl acetate (3 x 70 mL). The combined organic phases were washed with water (1 x 100 mL), dried over sodium sulfate and then volatile compounds were evaporated in vacuo to give an orange-red solid (5.3 g, 63 area% "Kresoxim-dimethyl" according to GC). The product was purified by medium- pressure column chromatography using silica 60 and heptane/ethyl acetate (7/1 ) eluent. Product-containing fractions were combined and dried in vacuo to give "Kresoxim-dimethyl" as a white solid (1.2 g).

GC: 97 area% Kresoxim-methyl.

GC/MS (El): [M]+ found (327).

1H NMR (CDCI3) δ = 7.59 (d, 1 H, J = 7.6 Hz, Harom), 7.46-7.35 (m, 2H, Harom), 7.20 (dd, 1 H, J1 = 7.4 Hz, J2 = 1.2 Hz, Harom), 7.00 (d, 1 H, J = 7.6 Hz, Harom), 6.66 (d, 1 H, J = 7.2 Hz), 6.58 (s, 1 H, Harom), 4.92 (s, 2H, CH2), 4.03 (s, 3H, NO-CH3), 3.82 (s, 3H, COOCH3), 2,28 (s, 3H, Ar-CH3), 2,25 (s, 3H, Ar-CH3).

13C NMR (CDCI3) δ = 163.2 (C=O), 156.4, 149.3 (C=N), 136.4, 135.8, 130.7, 130.4, 129.6, 128.9, 128.6, 128.4, 127.5, 123.7, 121.1 , 1 12.1 (all Carom), 67.9 (CH2), 63.8 (NOCH3), 52.9 (COOCH3), 21.4 (Ar-CH3), 15.8 (Ar-CH3).

"Kresoxim-dimethyl" (1.0 g, 3.1 mmol) was dissolved in dichloromethane (5 mL) and then methyl amine in methanol (24 w/w%, 2 mL) was added to the solution. The resulting mixture was stirred at room temperature. After 3 hours again methyl amine in methanol (24 w/w%, 2 mL) was added and the solution was allowed to stir at room temperature over the weekend. All volatile compounds were removed in vacuo to give the product Dimoxystrobin as a yellowish solid (0.73 g, 73 %).

GC: 98 area% Kresoxim-methyl.

GC/MS (El): [M]+ found (326).

Claims

An improved process for preparing o-chloromethylphenylglyoxylic esters of the formula
Figure imgf000018_0001
in which
R is a reaction-inert radical, n is from 0 to 4 and R1 may be a Ci-C8-alkyl radical, which comprises converting a compound of the formula
Figure imgf000018_0002
in which n and R are as defined above,
R2 and R3 independently of one another may be CrC^-alkyl,
Ci-Ci2-alkenyl,
Figure imgf000018_0003
or C3-C6-cycloalkyl or R2 and R3 together with the nitrogen atom may be a 6- or 7-membered ring which, in addition to the nitrogen atom, may contain a further nitrogen atom or oxygen atom, by reaction with magnesium into the corresponding Grignard reagent which is then reacted with a compound of the formula
Figure imgf000018_0004
(III) in which R1 is as defined above to give the compound of the formula
Figure imgf000019_0001
in which n, R, R1 , R2 and R3 are as defined above, which is then cleaved by reaction with a chloroformic ester of the formula CICOOR4 in which R4 may be a Ci.Cs-alkyl radical or by reaction with phosgene to give the compound of the formula (I), followed by the isolation of the compound of the formula (I).
2. The process as claimed in claim 1 wherein in the first step a solvent from the group of the ethers, the aromatic hydrocarbons or the amines or mixtures thereof is used.
3. The process as claimed in claim 1 wherein the compound of the formula (IV) is used directly as a suspension for the reaction with the chloroformic ester or phosgene.
4. A compound of the formula.
Figure imgf000019_0002
(IV) in which n, R, R1 , R2 and R3 are as defined in claim 1 , and its use for preparing agrochemically active compounds.
5. The compound of the formula
Figure imgf000020_0001
obtained by aqueous work-up of the compound of the formula (IV) in which n = O, R1 is methyl and R2 and R3 together with the nitrogen atom form a six-membered ring which additionally contains an oxygen atom, and its use for preparing agrochemically active compounds. The compound of the formula
Figure imgf000020_0002
obtained by oximation of the compound of the formula (V), and its use for preparing agrochemically active compounds. An improved process for preparing (E)-2-(2-chloromethylphenyl)-2- alkoximinoacetic esters of the formula
Figure imgf000020_0003
in which
R is a reaction-inert radical, n is from O to 4 and R1 and R5 independently of one another may be Ci-C8-alkyl radicals, which comprises treating a compound of the formula
Figure imgf000021_0001
in which n, R, R1 and R5 are as defined above, obtained by oximation of the compound of the formula (I), with an aqueous mineral acid. 8. The process as claimed in claim 7, wherein the mineral acid used is hydrochloric acid, sulfuric acid, phosphoric acid or nitric acid.
ABSTRACT
An improved process for preparing o-chloromethylphenylglyoxylic esters of the formula
Figure imgf000022_0001
which comprises converting a compound of the formula
Figure imgf000022_0002
-mayg5ήtain o further nitrogen atom or oxygon atorr^ by reaction with magnesium the corresponding Grignard reagent which is then reacted with a compound of the formula
Figure imgf000022_0003
to give the compound of the formula
Figure imgf000023_0001
which is then cleaved by reaction with a chloroformic ester of the formula CICOOR4 |o- which' R4 may bo o C1-CB alkyl rodicol/or by reaction with phosgene to give the compound of the formula (I), followed by the isolation of the compound of the formula (I), and also an improved process for preparing (E)-2-(2-chloromethylphenyl)- 2-alkoximinoacetic esters of the formula
Figure imgf000023_0002
ifhich R1 and R5 independently of one another may bo Ci C8 alkyl radicalsJand intermediates for their preparation.
PCT/EP2008/054354 2007-04-12 2008-04-10 Improved process for preparing o-chloromethylphenylglyoxylic esters, improved process for preparing (e)-2-(2-chloromethylphenyl)-2-alkoximinoacetic esters, and novel intermediates for their preparation WO2008125592B1 (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
AT5612007 2007-04-12
ATA561/2007 2007-04-12

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US12595113 US20100113778A1 (en) 2007-04-12 2008-04-10 Process for preparing o-chloromethylphenylglyoxylic esters, improved process for preparing (e)-2-(2-chloromethylphenyl)-2-alkoximinoacetic esters, and novel intermediates for their preparation
EP20080736074 EP2134673A1 (en) 2007-04-12 2008-04-10 Improved process for preparing o-chloromethylphenylglyoxylic esters, improved process for preparing (e)-2-(2-chloromethylphenyl)-2-alkoximinoacetic esters, and novel intermediates for their preparation
CN 200880020168 CN101711232A (en) 2007-04-12 2008-04-10 Improved process for preparing o-chloromethylphenylglyoxylic esters, improved process for preparing (e)-2-(2-chloromethylphenyl)-2-alkoximinoacetic esters, and novel intermediates for their preparation

Publications (2)

Publication Number Publication Date
WO2008125592A1 true true WO2008125592A1 (en) 2008-10-23
WO2008125592B1 true WO2008125592B1 (en) 2008-12-24

Family

ID=39689086

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/EP2008/054354 WO2008125592B1 (en) 2007-04-12 2008-04-10 Improved process for preparing o-chloromethylphenylglyoxylic esters, improved process for preparing (e)-2-(2-chloromethylphenyl)-2-alkoximinoacetic esters, and novel intermediates for their preparation

Country Status (4)

Country Link
US (1) US20100113778A1 (en)
EP (1) EP2134673A1 (en)
CN (1) CN101711232A (en)
WO (1) WO2008125592B1 (en)

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2009037230A2 (en) * 2007-09-17 2009-03-26 Dsm Fine Chemicals Austria Nfg Gmbh & Co Kg Improved process for preparing (e)-2-(2-chloromethylphenyl)-2-alkoximinoacetic esters
WO2010089267A2 (en) 2009-02-05 2010-08-12 Basf Se Method for producing 2-halogenomethylphenyl acetic acid derivatives
WO2015086490A1 (en) 2013-12-11 2015-06-18 Bayer Cropscience Ag Method for the preparation of halogenated di-substituted benzylamines, in particular halogenated dialkylbenzylamines

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7888354B2 (en) * 2007-11-13 2011-02-15 Taisho Pharmaceutical Co., Ltd Phenylpyrazole derivatives
EP3041819A1 (en) * 2013-09-04 2016-07-13 Taminco bvba Improved process for the reductive amination and selective hydrogenation of substrates containing a selected halogen
CN103787915B (en) * 2014-01-15 2015-10-07 京博农化科技股份有限公司 Trifloxystrobin one kind of intermediate (e) -2- (2- bromomethylphenyl) -2-methoxyimino acetate preparation
CN107001235A (en) 2014-11-04 2017-08-01 塔明克有限公司 Improved process for the reductive amination of halogen-containing substrates
US20170129847A1 (en) 2015-11-10 2017-05-11 Taminco Bvba Process for the reductive amination of halogen-containing substrates

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0782982A1 (en) * 1996-01-03 1997-07-09 Novartis AG Process for the preparation of o-chloro-methyl-phenylglyoxylic acid derivatives
EP0811612A1 (en) * 1996-05-28 1997-12-10 Sumitomo Chemical Company Limited Process for preparing dithiocarbonimide derivatives

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0782982A1 (en) * 1996-01-03 1997-07-09 Novartis AG Process for the preparation of o-chloro-methyl-phenylglyoxylic acid derivatives
EP0811612A1 (en) * 1996-05-28 1997-12-10 Sumitomo Chemical Company Limited Process for preparing dithiocarbonimide derivatives

Cited By (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2009037230A2 (en) * 2007-09-17 2009-03-26 Dsm Fine Chemicals Austria Nfg Gmbh & Co Kg Improved process for preparing (e)-2-(2-chloromethylphenyl)-2-alkoximinoacetic esters
WO2009037230A3 (en) * 2007-09-17 2009-07-09 Dsm Fine Chem Austria Gmbh Improved process for preparing (e)-2-(2-chloromethylphenyl)-2-alkoximinoacetic esters
WO2010089267A2 (en) 2009-02-05 2010-08-12 Basf Se Method for producing 2-halogenomethylphenyl acetic acid derivatives
WO2015086490A1 (en) 2013-12-11 2015-06-18 Bayer Cropscience Ag Method for the preparation of halogenated di-substituted benzylamines, in particular halogenated dialkylbenzylamines
CN105814012A (en) * 2013-12-11 2016-07-27 拜耳作物科学股份公司 Method for the preparation of halogenated di-substituted benzylamines, in particular halogenated dialkylbenzylamines
JP2017504583A (en) * 2013-12-11 2017-02-09 バイエル・クロップサイエンス・アクチェンゲゼルシャフト Halogen di-substituted benzyl amines, particularly method for producing halogenated dialkyl benzyl amine
US9670135B2 (en) 2013-12-11 2017-06-06 Bayer Cropscience Aktiengesellschaft Preparation of halogenated di-substituted benzylamines, particularly halogenated dialkylbenzylamines
CN105814012B (en) * 2013-12-11 2018-01-26 拜耳作物科学股份公司 Disubstituted benzylamine halogenated, in particular preparing a dialkyl halogenated benzylamine

Also Published As

Publication number Publication date Type
EP2134673A1 (en) 2009-12-23 application
US20100113778A1 (en) 2010-05-06 application
WO2008125592B1 (en) 2008-12-24 application
CN101711232A (en) 2010-05-19 application

Similar Documents

Publication Publication Date Title
EP0001500A1 (en) 1-Carbocyclic aryl-2-mono or -bis(alkoxycarbonyl) guanidino ethanes, and methods for their preparation and the preparation therefrom of 4,5-dihydro-2-alkoxycarbonylamino-5-carbocyclic aryl imidazoles
US5225585A (en) Production of fluoxetine and new intermediates
EP2062874A1 (en) Process and intermediates for the preparation of aliskiren
Avenoza et al. Enantioselective synthesis of (S)-and (R)-α-methylserines: application to the synthesis of (S)-and (R)-N-Boc-N, O-isopropylidene-α-methylserinals
Padwa et al. Synthesis of novel bicyclic nitrogen heterocycles by the intramolecular dipolar cycloaddition reaction of nitrones with allenes and alkynes
WO2000068221A1 (en) Salts of 2,2-dimethyl-1,3-dioxane intermediates and process for the preparation thereof
WO2003084919A2 (en) Method for preparing combretastatins
EP0535928A2 (en) Process for producing intermediates for use in production of alkoxyiminoacetamides
CN101153012A (en) Novel method of producing dronedarone key intermediate
EP0781764A1 (en) Process for producing alkoxyiminoacetamide derivative
US6759555B2 (en) Process for the preparation of combretastatins
JP2010539147A (en) Preparation of disubstituted piperidine and intermediates
WO1999052855A1 (en) A process for preparing chiral (s)-2,3-disubstituted-1-propylamine derivatives
JP2007326784A (en) Method for producing 1-substituted-5-fluoroalkylpyrazole-4-carboxylic acid ester
US5124489A (en) Process for preparing phenethanol ethers by the reduction of corresponding phenylglyoxal acetals
WO1998043948A1 (en) Process for preparing o-(3-amino-2-hydroxy-propyl)-hydroxymic acid halides
US5075504A (en) Process for the preparation of O-substituted hydroxylamines
US4395561A (en) Synthesis of 3-hydroxyoxetane
CN101193880A (en) Exo- and diastereo- selective syntheses of himbacine analogs
JP2003212861A (en) Method for producing pyrimidinyl alcohol derivative and synthetic intermediate thereof
US5304650A (en) Process for the preparation of alkyl N-(hydroxyalkyl)-carbamates
US5955627A (en) Process for the preparation of cyclopropylacetylene derivatives
US6333415B1 (en) Intermediates and processes for the preparation of optically active octanoic acid derivatives
US4231962A (en) 3-Phenoxybenzylideneamines and 3-benzylbenzylideneamines
WO1999014184A1 (en) Novel stereoselective processes for the preparation of gabapentin analogues

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 08736074

Country of ref document: EP

Kind code of ref document: A1

WWE Wipo information: entry into national phase

Ref document number: 6514/DELNP/2009

Country of ref document: IN

NENP Non-entry into the national phase in:

Ref country code: DE

WWE Wipo information: entry into national phase

Ref document number: 12595113

Country of ref document: US